Literature DB >> 26505673

Bent out of shape: α-Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease.

Esteban Luna1, Kelvin C Luk2.   

Abstract

Protein inclusions made up primarily of misfolded α-synuclein (α-Syn) are the hallmark of a set of disorders known as synucleinopathies, most notably Parkinson's disease (PD). It is becoming increasingly appreciated that α-Syn misfolding can spread to anatomically connected regions in a prion-like manner. The protein aggregates that ensue are correlated with neurodegeneration in the various yet select neuronal populations that are affected. Recent advances have begun to shed light on the spreading and toxicity mechanisms that may be occurring in PD. Several key emerging themes are arising from this work suggesting that α-Syn mediated neurodegeneration is due to a combination of relative α-Syn expression level, connectivity to affected brain regions, and intrinsic vulnerability to pathology.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alpha-synuclein; Neurodegeneration; Parkinson’s disease; Protein misfolding; Selective vulnerability

Mesh:

Substances:

Year:  2015        PMID: 26505673      PMCID: PMC4679620          DOI: 10.1016/j.febslet.2015.10.023

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  191 in total

1.  Nuclear localization of alpha-synuclein and its interaction with histones.

Authors:  John Goers; Amy B Manning-Bog; Alison L McCormack; Ian S Millett; Sebastian Doniach; Donato A Di Monte; Vladimir N Uversky; Anthony L Fink
Journal:  Biochemistry       Date:  2003-07-22       Impact factor: 3.162

2.  Activation of the unfolded protein response in Parkinson's disease.

Authors:  J J M Hoozemans; E S van Haastert; P Eikelenboom; R A I de Vos; J M Rozemuller; W Scheper
Journal:  Biochem Biophys Res Commun       Date:  2007-01-17       Impact factor: 3.575

3.  Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations.

Authors:  Z Gan-Or; N Giladi; A Orr-Urtreger
Journal:  Brain       Date:  2009-06-05       Impact factor: 13.501

4.  CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism.

Authors:  Robert M Silva; Vincent Ries; Tinmarla Frances Oo; Olga Yarygina; Vernice Jackson-Lewis; Elizabeth J Ryu; Phoebe D Lu; Stefan J Marciniak; David Ron; Serge Przedborski; Nikolai Kholodilov; Lloyd A Greene; Robert E Burke
Journal:  J Neurochem       Date:  2005-08-31       Impact factor: 5.372

5.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

6.  Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.

Authors:  John P Anderson; Donald E Walker; Jason M Goldstein; Rian de Laat; Kelly Banducci; Russell J Caccavello; Robin Barbour; Jiping Huang; Kristin Kling; Michael Lee; Linnea Diep; Pamela S Keim; Xiaofeng Shen; Tim Chataway; Michael G Schlossmacher; Peter Seubert; Dale Schenk; Sukanto Sinha; Wei Ping Gai; Tamie J Chilcote
Journal:  J Biol Chem       Date:  2006-07-17       Impact factor: 5.157

Review 7.  The origins of oxidant stress in Parkinson's disease and therapeutic strategies.

Authors:  Dalton James Surmeier; Jaime N Guzman; Javier Sanchez-Padilla; Joshua A Goldberg
Journal:  Antioxid Redox Signal       Date:  2010-12-15       Impact factor: 8.401

8.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

9.  Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells.

Authors:  Kelvin C Luk; Cheng Song; Patrick O'Brien; Anna Stieber; Jonathan R Branch; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

10.  The PINK1/Parkin pathway regulates mitochondrial morphology.

Authors:  Angela C Poole; Ruth E Thomas; Laurie A Andrews; Heidi M McBride; Alexander J Whitworth; Leo J Pallanck
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

View more
  21 in total

1.  Liquid-Liquid Phase Separation in Physiology and Pathophysiology of the Nervous System.

Authors:  Yasunori Hayashi; Lenzie K Ford; Luana Fioriti; Leeanne McGurk; Mingjie Zhang
Journal:  J Neurosci       Date:  2021-01-20       Impact factor: 6.167

2.  Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.

Authors:  P A Broderick; L Wenning; Y-S Li
Journal:  J Neural Transm (Vienna)       Date:  2016-10-28       Impact factor: 3.575

3.  Modification of C Terminus Provides New Insights into the Mechanism of α-Synuclein Aggregation.

Authors:  Kseniia Afitska; Anna Fucikova; Volodymyr V Shvadchak; Dmytro A Yushchenko
Journal:  Biophys J       Date:  2017-09-20       Impact factor: 4.033

4.  A sensitive assay reveals structural requirements for α-synuclein fibril growth.

Authors:  Dhruva D Dhavale; Christina Tsai; Devika P Bagchi; Laura A Engel; Jonathan Sarezky; Paul T Kotzbauer
Journal:  J Biol Chem       Date:  2017-04-03       Impact factor: 5.157

5.  Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.

Authors:  D J Covell; J L Robinson; R S Akhtar; M Grossman; D Weintraub; H M Bucklin; R M Pitkin; D Riddle; A Yousef; J Q Trojanowski; V M-Y Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2017-05-15       Impact factor: 8.090

Review 6.  Designer protein disaggregases to counter neurodegenerative disease.

Authors:  James Shorter
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

Review 7.  An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.

Authors:  Iris N Serratos; Elizabeth Hernández-Pérez; Carolina Campos; Michael Aschner; Abel Santamaría
Journal:  Mol Neurobiol       Date:  2021-11-08       Impact factor: 5.682

8.  Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.

Authors:  Fredric P Manfredsson; Kelvin C Luk; Matthew J Benskey; Aysegul Gezer; Joanna Garcia; Nathan C Kuhn; Ivette M Sandoval; Joseph R Patterson; Alana O'Mara; Reid Yonkers; Jeffrey H Kordower
Journal:  Neurobiol Dis       Date:  2018-01-16       Impact factor: 5.996

9.  Extensive Delayed Brain Atrophy after Resuscitation in a Patient with Multiple System Atrophy.

Authors:  Sazuku Nisitani; Hirofumi Miyoshi; Yoji Katsuoka
Journal:  Front Neurol       Date:  2018-01-15       Impact factor: 4.003

Review 10.  Confocal Spectroscopy to Study Dimerization, Oligomerization and Aggregation of Proteins: A Practical Guide.

Authors:  Yann Gambin; Mark Polinkovsky; Bill Francois; Nichole Giles; Akshay Bhumkar; Emma Sierecki
Journal:  Int J Mol Sci       Date:  2016-04-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.